Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comprehensive analysis of SARS‐CoV‐2 antibody dynamics in New Zealand
Alana L. Whitcombe, Reuben McGregor, Alyson Craigie, et al.
Clinical & Translational Immunology (2021) Vol. 10, Iss. 3
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronaviruses
Natalia Ortega, Marta Ribes, Marta Vidal, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 132
Dynamics of the SARS-CoV-2 antibody response up to 10 months after infection
Hao Wang, Yu Yuan, Mingzhong Xiao, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 7, pp. 1832-1834
Open Access | Times Cited: 51
IgG3 and IgM Identified as Key to SARS-CoV-2 Neutralization in Convalescent Plasma Pools
Christina Kober, Sandro Manni, Svenja Wolff, et al.
PLoS ONE (2022) Vol. 17, Iss. 1, pp. e0262162-e0262162
Open Access | Times Cited: 35
Contribution of infection and vaccination to population-level seroprevalence through two COVID waves in Tamil Nadu, India
T. S. Selvavinayagam, Anavarathan Somasundaram, Jerard Maria Selvam, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Mechanistic models of humoral kinetics following COVID-19 vaccination
Daniel Stocks, Amy Thomas, Adam Finn, et al.
Journal of The Royal Society Interface (2025) Vol. 22, Iss. 222
Open Access
Heterogenous humoral and cellular immune responses with distinct trajectories post-SARS-CoV-2 infection in a population-based cohort
Dominik Menges, Kyra D. Zens, Tala Ballouz, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 25
An acute rheumatic fever immune signature comprising inflammatory markers, IgG3, and Streptococcus pyogenes-specific antibodies
Natalie Lorenz, Reuben McGregor, Alana L. Whitcombe, et al.
iScience (2024) Vol. 27, Iss. 8, pp. 110558-110558
Open Access | Times Cited: 3
The Immune Response to SARS-CoV-2 and Variants of Concern
Elham Siasi Torbati, Kurt L. Krause, James E. Ussher
Viruses (2021) Vol. 13, Iss. 10, pp. 1911-1911
Open Access | Times Cited: 25
Nationally representative results on SARS-CoV-2 seroprevalence and testing in Germany at the end of 2020
Hannelore Neuhauser, Angelika Schaffrath Rosario, Hans Butschalowsky, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 16
Minding the margins: Evaluating the impact of COVID-19 among Latinx and Black communities with optimal qualitative serological assessment tools
Raquel A. Binder, Angela M. Matta, Catherine S. Forconi, et al.
PLoS ONE (2024) Vol. 19, Iss. 7, pp. e0307568-e0307568
Open Access | Times Cited: 2
Response kinetics of different classes of antibodies to SARS-CoV2 infection in the Japanese population: The IgA and IgG titers increased earlier than the IgM titers
Makoto Kurano, Yoshifumi Morita, Yuki Nakano, et al.
International Immunopharmacology (2021) Vol. 103, pp. 108491-108491
Open Access | Times Cited: 19
Germany’s low SARS-CoV-2 seroprevalence confirms effective containment in 2020: Results of the nationwide RKI-SOEP study
Hannelore Neuhauser, Angelika Schaffrath Rosario, Hans Butschalowsky, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 18
Immunogenicity of BNT162b2 COVID-19 vaccine in New Zealand adults
Frances Priddy, Michael A. Williams, Simon Carson, et al.
Vaccine (2022) Vol. 40, Iss. 34, pp. 5050-5059
Open Access | Times Cited: 12
Evaluation of independent self-collected blood specimens for COVID-19 antibody detection among the US veteran population
Tseli Mohammed, Jessica V. Brewer, Mary Pyatt, et al.
Diagnostic Microbiology and Infectious Disease (2022) Vol. 104, Iss. 2, pp. 115770-115770
Open Access | Times Cited: 12
Cohort profile: A Québec-based plasma donor biobank to study COVID-19 immunity (PlasCoV)
Marc Germain, Antoine Lewin, Renée Bazin, et al.
BMJ Open (2023) Vol. 13, Iss. 2, pp. e068803-e068803
Open Access | Times Cited: 7
Risk assessment and antibody responses to SARS-CoV-2 in healthcare workers
Amit Bansal, Mai-Chi Trieu, Kristin G. I. Mohn, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 7
Volumetric Absorptive Microsampling: Its Use in Covid-19 Research and Testing
James Rudge, Stuart Kushon
Bioanalysis (2021) Vol. 13, Iss. 24, pp. 1851-1863
Open Access | Times Cited: 17
Persistent humoral immune response in youth throughout the COVID-19 pandemic: prospective school-based cohort study
Alessia Raineri, Thomas Radtke, Sonja Rueegg, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 5
An eight-plex immunoassay for Group A streptococcus serology and vaccine development
Alana L. Whitcombe, Franklin Han, Sonia McAlister, et al.
Journal of Immunological Methods (2021) Vol. 500, pp. 113194-113194
Closed Access | Times Cited: 13
Longitudinal kinetics of RBD+ antibodies in COVID-19 recovered patients over 14 months
Tsuf Eyran, Anna Vaisman‐Mentesh, David Taussig, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 6, pp. e1010569-e1010569
Open Access | Times Cited: 9
Neutralizing-antibody response to SARS-CoV-2 for 12 months after the COVID-19 workplace outbreaks in Japan
Azumi Ishizaki, Xiuqiong Bi, Quynh Thi Nguyen, et al.
PLoS ONE (2022) Vol. 17, Iss. 8, pp. e0273712-e0273712
Open Access | Times Cited: 9
Mechanistic models of humoral kinetics following COVID-19 vaccination
Daniel Stocks, Amy Thomas, Adam Finn, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Establishing SARS-CoV-2 membrane protein-specific antibodies as a valuable serological target via high-content microscopy
Daniel M. Williams, Hailey Hornsby, Ola M. Shehata, et al.
iScience (2023) Vol. 26, Iss. 7, pp. 107056-107056
Open Access | Times Cited: 4
RSV Neutralizing Antibodies in Dried Blood
Jonne Terstappen, Eveline M. Delemarre, Anouk Versnel, et al.
The Journal of Infectious Diseases (2023) Vol. 230, Iss. 1, pp. e93-e101
Open Access | Times Cited: 4
Immunogenic SARS-CoV-2 S and N Protein Peptide and Cytokine Combinations as Biomarkers for Early Prediction of Fatal COVID-19
Ekaterina Martynova, Shaimaa Hamza, Maria Markelova, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top